SH
Saravanan Haritha
About Saravanan Haritha
Data last updated:
Saravanan Haritha is a Director at Larivin Pharma Private Limited (since 2025). The company operates in Paper. Larivin Pharma Private Limited reported revenue of ₹12.83 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Larivin Pharma Private Limited U21001TN2023PTC161631 | Director | 04 Apr 2025 | 2023 | ₹12.83 Cr (FY 2024) | Active |
Board colleagues of Saravanan Haritha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Natesavalavan Monalisa | 10626373 | Larivin Pharma Private Limited | Director |
| Ramaiyan Natesavalavan | 01892729 | Larivin Pharma Private Limited | Director |
| Saravanan Nambiyappan | 02057224 | Larivin Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Saravanan Haritha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Saravanan Haritha
Saravanan Haritha currently holds 1 directorship: Larivin Pharma Private Limited (Director, since 04 Apr 2025, revenue ₹12.83 Cr (FY 2024)).
Saravanan Haritha was first appointed on 04 Apr 2025 as Director at Larivin Pharma Private Limited.
The current boards of Saravanan Haritha's companies include Natesavalavan Monalisa (Larivin Pharma Private Limited), Ramaiyan Natesavalavan (Larivin Pharma Private Limited), Saravanan Nambiyappan (Larivin Pharma Private Limited).